T: primary tumor | | | | | | | |
TX | Primary tumor cannot be assessed | | | | | | |
T0 | No evidence of primary tumor | | | | | | |
Tis | Carcinoma in situ | | | | | | |
T1a | Tumor 5 mm or less in greatest dimension | | | | | | |
T1b | Tumor greater than 5 mm and less than 1 cm in greatest dimension | | | | | | |
T1c | Tumor greater than 1 cm but no more than 2 cm in greatest dimension | | | | | | |
T2 | Tumor more than 2 cm but no more than 4 cm in greatest dimension | | | | | | |
T3 | Tumor and more than 4 cm in greatest dimension | | | | | | |
T4 | Tumor involves celiac axis, superior mesenteric artery or common hepatic artery | | | | | | |
N: regional lymph nodes | | | | | | | |
NX | Regional lymph nodes cannot be assessed | | | | | | |
N0 | No regional lymph node metastasis | | | | | | |
N1 | Metastasis in 1?3 regional lymph nodes | | | | | | |
N2 | Metastasis in 4 or more regional lymph nodes | | | | | | |
M: distant metastasis | | | | | | | |
M0 | No distant metastasis | | | | | | |
M1 | Distant metastasis | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |